Argenx Se (ARGX) Tax Provisions (2017 - 2026)
Argenx Se's (ARGX) quarterly Tax Provisions came in at $59.0 million in Q2 2026, down 44.86% YoY from $107.0 million in Q2 2025, and down 1.67% on a QoQ basis from $60.0 million in Q1 2026.
Analysis
Argenx Se (ARGX) Tax Provisions (2017 - 2026) Analysis & Trends
Argenx Se (ARGX) has 8 years of Tax Provisions data on file, last reported at $59.0 million in Q2 2026.
- Quarterly Tax Provisions fell 44.86% year-over-year to $59.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $193.0 million (up 206.9% YoY) and the FY2025 annual result came in at -$13.4 million, up 98.2% from the prior year.
- Tax Provisions fell to $59.0 million in Q2 2026, from $60.0 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $107.0 million in Q2 2025 to a low of -$33.0 million in Q1 2025.
- A 3-year average of $30.3 million and a median of $36.5 million in 2022 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 281.82% in 2026, down 44.86% in 2026.
- Tracing ARGX's Tax Provisions over 3 years: stood at -$25.2 million in 2022, then jumped by 524.89% to $107.0 million in 2025, then sank by 44.86% to $59.0 million in 2026.
- The last three Tax Provisions figures came in at $59.0 million (Q2 2026), $60.0 million (Q1 2026), and $107.0 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.68 Bn | 131.82 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.68 Bn | 77.68 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.67 Bn | 58.48 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 57.02 Bn | 51.88 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 43.83 Bn | 43.83 Bn | - | - |
| 6 | BeOne Medicines | 39.97 Bn | 34.87 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.23 Bn | 31.93 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.56 Bn | 27.72 Bn | - | - |
| 9 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | 165.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -59.00 Mn |
| Mar 31, 2026 | -60.00 Mn |
| Dec 31, 2025 | 129.66 Mn |
| Sep 30, 2025 | -41.80 Mn |
| Jun 30, 2025 | -41.54 Mn |
| Mar 31, 2025 | -33.00 Mn |
| Dec 31, 2024 | 687.65 Mn |
| Sep 30, 2024 | 3.39 Mn |
| Jun 30, 2024 | 44.07 Mn |
| Mar 31, 2024 | 12.75 Mn |
| Dec 31, 2023 | -37.99 Mn |
| Sep 30, 2023 | 10.64 Mn |
| Jun 30, 2023 | -10.51 Mn |
| Mar 31, 2023 | 47.31 Mn |
| Dec 31, 2022 | 2.63 Mn |
| Sep 30, 2022 | 5.98 Mn |
| Jun 30, 2022 | 8.23 Mn |
| Mar 31, 2022 | 2.89 Mn |
| Dec 31, 2021 | 7.06 Mn |
| Sep 30, 2021 | -2.75 Mn |